Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT03914742Phase 1/2Completed
BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
IDH1 MutationIDH2 MutationRecurrent Glioblastoma+2 more
StudychairStart date: 2020-02-16

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ranjit Bindra, MD

ABTC/Yale University

Similar
1 trials

Shared therapeutic areas:

IDH1 MutationIDH2 MutationRecurrent Glioblastoma+2 more

Worked with same sponsors:

BeiGeneNational Cancer Institute (NCI)+1 more
Collaborated on 1 trial
Similarity Score54%

Behnam Badie

City of Hope Medical Center

Related
6 trials

Shared therapeutic areas:

Recurrent GlioblastomaRecurrent WHO Grade II GliomaRecurrent WHO Grade III Glioma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score18%

Thomas A Hope, MD

University of California, San Francisco

Related
7 trials

Shared therapeutic areas:

Recurrent GlioblastomaRecurrent WHO Grade III Glioma
Similarity Score12%

Jana L Portnow

City of Hope Medical Center

Related
4 trials

Shared therapeutic areas:

Recurrent GlioblastomaRecurrent WHO Grade III Glioma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score12%

Ugur T. Sener, MD

Mayo Clinic in Rochester

Related
3 trials

Shared therapeutic areas:

Recurrent Glioblastoma
Similarity Score6%

Tracy Batchelor, MD, MPH

Massachusetts General Hospital

Related
5 trials

Shared therapeutic areas:

Recurrent Glioblastoma

Worked with same sponsors:

National Cancer Institute (NCI)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Similarity Score6%

Benjamin M Ellingson

UCLA / Jonsson Comprehensive Cancer Center

Related
3 trials

Shared therapeutic areas:

Recurrent Glioblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Lisa Franklin

Istari Oncology

Related
3 trials

Shared therapeutic areas:

Recurrent Glioblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Jane Robertson

AstraZeneca

Related
10 trials

Shared therapeutic areas:

Recurrent Glioblastoma
Similarity Score6%

Jiayi Chen, MD

Ruijin Hospital

Related
3 trials

Shared therapeutic areas:

Recurrent Glioblastoma
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03914742Phase 1/2StudyChair

BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations

IDH1 MutationIDH2 MutationRecurrent Glioblastoma+2 more
Completed

All 1 trials loaded